- Home
- GMED vs ASND Comparison
GMED vs ASND Comparison
Compare GMED & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- ASND
- Stock Information
- Founded
- GMED 2003
- ASND 2006
- Country
- GMED United States
- ASND Denmark
- Employees
- GMED N/A
- ASND N/A
- Industry
- GMED Medical/Dental Instruments
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- GMED Health Care
- ASND Health Care
- Exchange
- GMED Nasdaq
- ASND Nasdaq
- Market Cap
- GMED 7.9B
- ASND 12.0B
- IPO Year
- GMED 2012
- ASND 2015
- Fundamental
- Price
- GMED $62.83
- ASND $199.77
- Analyst Decision
- GMED Buy
- ASND Strong Buy
- Analyst Count
- GMED 13
- ASND 17
- Target Price
- GMED $87.30
- ASND $245.76
- AVG Volume (30 Days)
- GMED 1.3M
- ASND 464.3K
- Earning Date
- GMED 11-06-2025
- ASND 11-13-2025
- Dividend Yield
- GMED N/A
- ASND N/A
- EPS Growth
- GMED 745.36
- ASND N/A
- EPS
- GMED 2.57
- ASND N/A
- Revenue
- GMED $2,626,461,000.00
- ASND $576,332,355.00
- Revenue This Year
- GMED $15.62
- ASND $102.31
- Revenue Next Year
- GMED $8.00
- ASND $76.44
- P/E Ratio
- GMED $24.38
- ASND N/A
- Revenue Growth
- GMED 17.43
- ASND 54.50
- 52 Week Low
- GMED $51.79
- ASND $118.03
- 52 Week High
- GMED $94.93
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- GMED 65.11
- ASND 45.67
- Support Level
- GMED $56.52
- ASND $186.05
- Resistance Level
- GMED $61.01
- ASND $214.47
- Average True Range (ATR)
- GMED 1.72
- ASND 7.57
- MACD
- GMED 0.44
- ASND -0.82
- Stochastic Oscillator
- GMED 98.13
- ASND 47.77
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.